Mumbai: Oracle has announced the launch of Oracle Health Sciences Clinical One Platform, a cloud-based eClinical environment that is intended to redefine the way technology supports clinical research, during a roadshow in Mumbai. Oracle also announced Clinical One Randomization and Supplies Management.
Developing a potentially life-saving drug from a promising molecule to an FDA-approved therapy can take more than a decade and cost billions of dollars due to redundant processes, increasing volumes and variety of patient data, and older technology systems that don’t communicate with one another. Oracle Health Sciences is tackling these issues with its Clinical One Platform, a new cloud-based eClinical solution that will unify clinical development operations and information in a single environment with shared functions and an easy-to-use interface for sites, clinical coordinators and their counterparts.
Unlike other products in the market, which are point solutions that address only a single part of the drug development lifecycle or a single area within clinical research, Clinical One Platform is a holistic, unified cloud environment. It is being built from the ground-up to address the needs of the entire drug development lifecycle – everyone and every process required to get a drug to market. The vision for its Clinical One Platform is to bring more drugs to market faster and offer hope for more cures by eliminating redundancies, creating process efficiencies and sharing information—in a way that has never been done before.